Expression of ADAMTS‑1 mRNA in myocardium of viral heart disease mice and its clinical significance

Li,Hongmei; Zhou,Yanchun; Song,Wei; Li,Jianxiu; Xu,Jingtao

doi:10.3892/etm.2018.6894

Expression of ADAMTS‑1 mRNA in myocardium of viral heart disease mice and its clinical significance

Authors:
- Hongmei Li
- Yanchun Zhou
- Wei Song
- Jianxiu Li
- Jingtao Xu
View Affiliations

Affiliations: Department of Cardiology, Yidu Central Hospital of Weifang, Weifang, Shandong 262500, P.R. China, Department of Psychology, Yidu Central Hospital of Weifang, Weifang, Shandong 262500, P.R. China, Department of Cardiovascular Medicine, Yidu Central Hospital of Weifang, Weifang, Shandong 262500, P.R. China, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China
Published online on: October 25, 2018 https://doi.org/10.3892/etm.2018.6894
Pages: 153-158
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The expression of ADAMTS‑1 mRNA in myocardium of viral heart disease (VHD) mice was investigated to explore its role in myocardial fibrosis. A total of 150 purebred inbred Balb/c mice were used in this study. According to the principle of similar body weight, 50 mice were selected to make an acute viral myocarditis (VMC) animal model (acute VMC group), and 50 mice were selected to make a chronic VMC animal model (chronic VMC group), and the remaining 50 mice were selected as a control group. RT‑qPCR was used to detect the relative expression of transforming growth factor‑β1 (TGF‑β1) mRNA and ADAMTS‑1 mRNA in myocardial tissue of three groups of mice, and their relationship in myocardial fibrosis was analyzed. Compared with the control group, the collagen volume fraction (CVF) in the myocardial tissue of the acute VMC group was significantly increased, and the increase of CVF in the myocardial tissue of the chronic VMC group was the most significant (p<0.001). Compared with the control group, the relative expression of TGF‑β1 mRNA and ADAMTS‑1 mRNA in myocardial tissue of the mice in the acute and chronic VMC group were significantly increased (p<0.001). The relative expression of TGF‑β1 mRNA and ADAMTS‑1 mRNA in myocardial tissue of chronic VMC group was significantly higher than that of acute VMC group (p<0.001). Pearson's correlation test results showed that ADAMTS‑1 mRNA was positively correlated with CVF and TGF‑β1 mRNA, and the correlation coefficients were (r=0.351, p<0.01, r=0.401, p<0.01). ADAMTS‑1 is involved in the occurrence and development of myocardial fibrosis, and it is positively correlated with CVF and TGF‑β1. It may play a role in promoting myocardial fibrosis during the development of VHD. It can be used as a biological index for predicting myocardial fibrosis.

View Figures

View References

1	Yuan J, Liao YH, Jin XJ, Wang ZH, Yu M, Chen RZ, Xu DJ, Wei J, Wan J, Zhao DC, et al: Continued elevation of plasma IL-4 and IL-17 predicts the progression from viral myocarditis to dilated cardiomyopathy. Eur Heart J. 38 (suppl 1):P51432017. View Article : Google Scholar
2	Clemente-Casares X, Hosseinzadeh S, Barbu I, Dick SA, Macklin JA, Wang Y, Momen A, Kantores C, Aronoff L, Farno M, et al: A CD103⁺ conventional dendritic cell surveillance system prevents development of overt heart failure during subclinical viral myocarditis. Immunity. 47:974–989.e8. 2017. View Article : Google Scholar : PubMed/NCBI
3	Becher PM, Gotzhein F, Klingel K, Escher F, Blankenberg S, Westermann D and Lindner D: Cardiac function remains impaired despite reversible cardiac remodeling after acute experimental viral myocarditis. J Immunol Res. 2017:65906092017. View Article : Google Scholar : PubMed/NCBI
4	Jin SA, Lim BK, Kim SK, Seo HJ, Seo BS, Kwon HJ, Seong SW, Jeong JO and Seong IW: Identification of serum apurinic/apyrimidinic endonuclease 1/redox effector factor-1 (APE1/Ref-1) in mouse model of viral myocarditis; implication of a novel biomarker for myocarditis. Eur Heart J. 38 (suppl 1):35152017. View Article : Google Scholar
5	Lurz JA, Luecke C, Lang D, Besler C, Rommel KP, Klingel K, Kandolf R, Adams V, Schöne K, Hindricks G, et al: CMR-derived extracellular volume fraction as a marker for myocardial fibrosis: The importance of coexisting myocardial inflammation. JACC Cardiovasc Imaging. 11:38–45. 2018. View Article : Google Scholar : PubMed/NCBI
6	Zhou B and Yu JW: A novel identified circular RNA, circRNA_010567, promotes myocardial fibrosis via suppressing miR-141 by targeting TGF-β1. Biochem Biophys Res Commun. 487:769–775. 2017. View Article : Google Scholar : PubMed/NCBI
7	Tola EN, Karatopuk DU, Koroglu N, Ergin M and Oral HB: Follicular ADAMTS-1 and aggrecan levels in polycystic ovary syndrome. J Assist Reprod Genet. 34:811–816. 2017. View Article : Google Scholar : PubMed/NCBI
8	Tang H, Lee M, Kim EH, Bishop D and Rodgers GM: siRNA-knockdown of ADAMTS-13 modulates endothelial cell angiogenesis. Microvasc Res. 113:65–70. 2017. View Article : Google Scholar : PubMed/NCBI
9	Rittié L: Method for picrosirius red-polarization detection of collagen fibers in tissue sections. Methods Mol Biol. 1627:395–407. 2017. View Article : Google Scholar : PubMed/NCBI
10	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
11	Schelbert EB, Fridman Y, Wong TC, Abu Daya H, Piehler KM, Kadakkal A, Miller CA, Ugander M, Maanja M, Kellman P, et al: Temporal relation between myocardial fibrosis and heart failure with preserved ejection fraction: Association with baseline disease severity and subsequent outcome. JAMA Cardiol. 2:995–1006. 2017. View Article : Google Scholar : PubMed/NCBI
12	Francone M: Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: Diagnostic contribution and prognostic significance. ISRN Radiol. 2014:3654042014. View Article : Google Scholar : PubMed/NCBI
13	Chen CY, Su MY, Lin LY, Tsai CT, Wang YC, Lin YH, Lee JK, Wu CK, Juang JM, Huang JJ, et al: Congenital hypertrophic cardiomyopathy with genetic mutations is highly associated with left ventricular myocardial fibrosis and larger right ventricle (TW-HCM study). Eur Heart J. 38 (suppl_1):40972017. View Article : Google Scholar
14	Fang L, Ellims AH, Beale AL, Taylor AJ, Murphy A and Dart AM: Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy. Am J Transl Res. 9:5063–5073. 2017.PubMed/NCBI
15	Spartera M, Damascelli A, Mozes F, De Cobelli F and La Canna G: Three-dimensional speckle tracking longitudinal strain is related to myocardial fibrosis determined by late-gadolinium enhancement. Int J Cardiovasc Imaging. 33:1351–1360. 2017. View Article : Google Scholar : PubMed/NCBI
16	Arbustini E, Favalli V and Narula N: Extracellular volume in dilated cardiomyopathy: Interstitial fibrosis and more? JACC Cardiovasc Imaging. 11:60–63. 2018. View Article : Google Scholar : PubMed/NCBI
17	Guo Y, Gupte M, Umbarkar P, Singh AP, Sui JY, Force T and Lal H: Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis. J Mol Cell Cardiol. 110:109–120. 2017. View Article : Google Scholar : PubMed/NCBI
18	Hong SK, Choo EH, Ihm SH, Chang K and Seung KB: Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis by inhibiting transforming growth factor-βl and Smad2/3 pathways in high-fat diet-induced obesity rat model. Metabolism. 76:42–55. 2017. View Article : Google Scholar : PubMed/NCBI
19	Dzeshka MS, Appadoo K, Shantsila E, Snezhitskiy VA and Lip GYH: Increased evidence of left ventricular myocardial fibrosis in patients with paroxysmal atrial fibrillation and sinus node dysfunction. Eur Heart J. 38:P17202017. View Article : Google Scholar
20	Salvarani N, Maguy A, De Simone SA, Miragoli M, Jousset F and Rohr S: TGF-β1 (transforming growth factor-β1) plays a pivotal role in cardiac myofibroblast arrhythmogenicity. Circ Arrhythm Electrophysiol. 10:e0045672017. View Article : Google Scholar : PubMed/NCBI
21	Dubey D, McRae PA, Rankin-Gee EK, Baranov E, Wandrey L, Rogers S and Porter BE: Increased metalloproteinase activity in the hippocampus following status epilepticus. Epilepsy Res. 132:50–58. 2017. View Article : Google Scholar : PubMed/NCBI
22	Mittaz L, Ricardo S, Martinez G, Kola I, Kelly DJ, Little MH, Hertzog PJ and Pritchard MA: Neonatal calyceal dilation and renal fibrosis resulting from loss of Adamts-1 in mouse kidney is due to a developmental dysgenesis. Nephrol Dial Transplant. 20:419–423. 2005. View Article : Google Scholar : PubMed/NCBI
23	Ng YH, Zhu H, Pallen CJ, Leung PC and MacCalman CD: Differential effects of interleukin-1beta and transforming growth factor-beta1 on the expression of the inflammation-associated protein, ADAMTS-1, in human decidual stromal cells in vitro. Hum Reprod. 21:1990–1999. 2006. View Article : Google Scholar : PubMed/NCBI